newsfilter
← Latest News
GlobeNewswire·

Verve Therapeutics to Participate in Upcoming Investor Conferences

BOSTON , May 28, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that management will participate in